These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27177805)

  • 1. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.
    Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
    Blanken P; Nuijten M; van den Brink W; Hendriks VM
    Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial.
    Nuijten M; Blanken P; van de Wetering B; Nuijen B; van den Brink W; Hendriks VM
    Lancet; 2016 May; 387(10034):2226-34. PubMed ID: 27015909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.
    Blanken P; Hendriks VM; van Ree JM; van den Brink W
    Addiction; 2010 Feb; 105(2):300-8. PubMed ID: 19922517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craving and illicit heroin use among patients in heroin-assisted treatment.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
    Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
    Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diacetylmorphine versus methadone for the treatment of opioid addiction.
    Oviedo-Joekes E; Brissette S; Marsh DC; Lauzon P; Guh D; Anis A; Schechter MT
    N Engl J Med; 2009 Aug; 361(8):777-86. PubMed ID: 19692689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review.
    McNair R; Monaghan M; Montgomery P
    Drug Alcohol Depend; 2023 Jun; 247():109869. PubMed ID: 37086659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against.
    Epstein DH; Preston KL
    Addiction; 2003 Mar; 98(3):269-79. PubMed ID: 12603227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial.
    Haasen C; Eiroa-Orosa FJ; Verthein U; Soyka M; Dilg C; Schäfer I; Reimer J
    Alcohol; 2009 Jun; 43(4):259-64. PubMed ID: 19375884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticipated effects of experimental heroin prescription on the method of administration and the use of other drugs].
    Benschop A; Hendriks VM; Blanken P
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):292-5. PubMed ID: 9148165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.
    Oviedo-Joekes E; Nosyk B; Marsh DC; Guh D; Brissette S; Gartry C; Krausz M; Anis A; Schechter MT
    Clin Trials; 2009 Jun; 6(3):261-71. PubMed ID: 19528135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials.
    Castells X; Kosten TR; Capellà D; Vidal X; Colom J; Casas M
    Am J Drug Alcohol Abuse; 2009; 35(5):339-49. PubMed ID: 20180662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.